贝复济治疗Ⅱ度烧伤的上市后药物经济学评价  

Pharmacoeconomics Evaluation of rb-bFGF for Burn Wound Degree Ⅱ

作　　者：潘岳松[1] 彭晓霞[2] 

机构地区：[1]首都医科大学附属北京儿童医院,北京100045 [2]首都医科大学公共卫生与家庭医学学院流行病学与卫生统计学系,北京100069

出　　处：《中国执业药师》2010年第3期28-32,共5页China Licensed Pharmacist

摘　　要：目的:基于对贝复济治疗II度烧伤的成本-效果分析基础上,进行上市后的预算影响分析。方法:基于已完成的贝复济治疗Ⅱ度烧伤的临床Ⅲ期试验数据库,回顾性收集费用数据,然后进行成本-效果分析与预算影响分析。结果:贝复济组较对照组,可以缩短烧伤创面的愈合时间,平均为2.78天。预算影响分析则提示:贝复济治疗组每增加1个效果单位(愈合时间缩短1天)所花成本比对照组节约934.53元。结论:贝复济治疗II度烧伤是有效、安全、经济的,我们的研究结果将为卫生行政和医疗保险部门的决策提供科学依据。Objectives：To evaluate the pharmacoeconomics of rb-bFGF for burn wound degree II.Methods：Database of clinical trial of rb-bFGF against burn wound degree II was re-analyzed and their cost in case report form （CRF） was collected retrospectively.Incremental cost-effectiveness analysis was used to evaluate the pharmacoeconomics effectiveness of the rb-bFGF.Budget impact analysis was conducted in order to make innovative drug reimbursement decision.Results：2.78 days was ahead to recover in the treat group using rb-bFGF with comparison with the control group.934.53 yuan could be saved from the total cost when 1 day was ahead to recover in the patient being treated by rb-bFGF.Conclusions：The rb-bFGF is effective,safe and economic to treat burn wound degree II.

关 键 词：Ⅱ度烧伤 成本-效果分析 预算影响分析 

分 类 号：R711.320.5[医药卫生—妇产科学]